Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC72H78Cl4N8O15 |
InChIKeyKECKJSNYFPFODX-PINBWVOXSA-N |
CAS Registry2249750-23-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 03 Apr 2020 |